300289.SZ
利德曼
SZSE · Healthcare · C 制造业 · CN
CNY 5.75
−3.20%Year over year
Reported trailing growth
- Revenue
- -10.3%
- EBITDA
- —
- EBIT
- +72.1%
- EPS
- +66.8%
- Free cash flow
- -89.2%
- Operating cash flow
- -59.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -22.7%
- EBITDA
- -20.2%
- EBIT
- +76.3%
- Net income
- +69.4%
- EPS
- +71.4%
- Free cash flow
- -45.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026